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Abstract: 1 
Chronic infections have been a major topic of investigation in recent years, but 2 
the mechanisms that dictate whether or not a pathogen is successfully controlled 3 
are incompletely understood. Cytomegalovirus (CMV) is a herpesvirus that 4 
establishes a persistent infection in the majority of people in the world. Like other 5 
herpesviruses, CMV is well controlled by an effective immune response and 6 
induces little, if any, pathology in healthy individuals. However, controlling CMV 7 
requires continuous immune surveillance and thus, CMV is a significant cause of 8 
morbidity and death in immune compromised individuals. T cells in particular play 9 
an important role in controlling CMV and both CD4+ and CD8+ CMV-specific T 10 
cells are essential. These virus-specific T cells persist in exceptionally large 11 
numbers during the infection, traffic into peripheral tissues and remain functional, 12 
facts that make CMV an attractive vaccine vector for driving “CMV-like” T cell 13 
responses against recombinant antigens of choice. However, the mechanisms by 14 
which these T cells persist and differentiate while remaining functional are still 15 
poorly understood and we have no means to promote their development in 16 
immune compromised patients at risk for CMV disease. In this review, I will 17 
briefly summarize our current knowledge of CMV-specific CD8+ T cells and 18 
propose a mechanism that may explain their maintenance and preservation of 19 
function during chronic infection. 20 
 21 
Introduction: CMV latency and persistence 22 
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Herpesviruses are large DNA viruses that evolved an estimated 180 to 220 1 
million years ago and have been co-speciating with their hosts ever since [1], 2 
resulting in a very finely tuned host-pathogen balance. Herpesviruses establish 3 
persistent or latent infections and induce little, if any, pathology in healthy hosts, 4 
thanks largely to sustained, functional immune responses. Cytomegalovirus 5 
(CMV) is a ubiquitous member of the β-subfamily of herpesviruses. Primary CMV 6 
infection typically occurs in childhood and is usually asymptomatic. After an 7 
active phase during which infectious virions are shed, CMV is controlled to levels 8 
that are at, or just below what is readily detectable. Despite substantial 9 
investigation, CMV remains an enigmatic virus and much of the viral behavior 10 
during the persistent/latent phase of infection remains a mystery. However, 11 
persistent CMV infection is characterized by periods of viral reactivation and 12 
shedding, and constant immune surveillance is vital to keep CMV under control.  13 
 14 
Our understanding of the ongoing host-virus interaction that keeps CMV in check 15 
is somewhat limited, in part because the cells harboring latent virus or presenting 16 
viral antigen during persistent infection are still incompletely defined. Several 17 
groups have identified latent human CMV (HCMV) in hematopoietic progenitor 18 
cells or monocyte/macrophages (reviewed in [2]). However, work in mice 19 
suggests that hematopoietic cells are only part of the picture. Murine CMV 20 
(MCMV) is a natural mouse pathogen and the homologue of human CMV. Both 21 
viruses induce similar infections and are controlled by similar immune responses. 22 
Like HCMV, MCMV is also thought to establish latency in macrophages [3, 4]. 23 
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However, after primary infection, MCMV viral DNA is cleared from the blood and 1 
bone marrow but not the salivary glands, lungs or spleen [5] suggesting that 2 
relatively little of the MCMV genome is maintained by blood-derived cells. 3 
Moreover, in the spleens of chronically infected mice, viral reactivation in explant 4 
cultures was most easily detected in the stromal fraction and was unaffected by 5 
depletion of lymphocytes or MHC class II bearing cells [6], again suggesting a 6 
major non-hematopoietic site of MCMV latency. Endothelial cells have been 7 
identified as one such non-hematopoietic site of MCMV latency [3, 7] and it is 8 
likely that non-hematopoietic sites of latency, particularly endothelial cells [8], are 9 
important for HCMV as well. Additional sites of latency are also likely and the 10 
degree to which each contributes to the maintenance of the latent viral pool will 11 
be of significant interest.  12 
 13 
Initially, there was substantial debate about whether CMV remained persistent 14 
(i.e. constantly replicating at a low rate) or achieved true molecular latency at late 15 
times post infection. While it is now generally accepted that CMV achieves true 16 
molecular latency, it is also evident that the virus undergoes frequent 17 
reactivation. Landmark experiments by Reddehase and colleagues showed that 18 
despite ubiquitous viral DNA in the lungs of mice infected for 12 months, viral 19 
RNA in the lungs was expressed in a patchwork pattern [9]. These data 20 
suggested that viral reactivation occurred frequently, but only in a fraction of 21 
infected cells at any given time. This group further showed that the patchwork 22 
viral reactivation rarely led to the production of infectious virions [10]. In order to 23 
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replicate, CMV transcribes its genes in an ordered cascade that begins with 1 
immediate early (IE) genes followed by early (E) genes, DNA replication and 2 
ultimately late (L) genes that encode structural virion components. While the 3 
patchwork expression of viral RNA in the lungs frequently included IE genes, as 4 
shown previously, E and L genes were undetectable [10]. Similarly, infectious 5 
virus was undetectable even with techniques that allowed detection of as few as 6 
5 viral genomes [11]. Importantly, this group has also shown that MCMV-specific 7 
CD8+ T cells block the progression of viral gene expression during reactivation 8 
[12], indicating that immune surveillance contributes to the suppression of virion 9 
production. These data show that CMV is present in a latent state and that 10 
reactivation occurs frequently, but also that reactivation is usually aborted or 11 
blocked prior to complete gene expression and production of virions.  12 
 13 
Overall, the data suggest that CMV is constantly pressuring the immune system. 14 
Compromising the immune system of CMV-infected individuals frequently results 15 
in disseminated viral replication and substantial morbidity and death. Many arms 16 
of the immune system contribute to viral control. Interferons, natural killer (NK) 17 
cells, CD4+ T cells, CD8+ T cells and antibody all play a recognized role in 18 
controlling viral replication and spread [13]. Once latency is established, viral 19 
reactivation seems to be largely controlled by the combined efforts of NK cells, 20 
CD4+ and CD8+ T cells [14], though the specific contributions of these cells 21 
remain more obscure. CD4+ T cells play a direct role in controlling viral 22 
replication, likely by cytokine secretion or cytotoxicity [15-18]. In addition, CMV-23 
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specific CD4+ T cells may help CMV-specific CD8+ T cell responses [19-21]. 1 
CD8+ T cells for their part, have been shown to directly limit viral reactivation in 2 
healthy mice [12] and can control viral replication in otherwise 3 
immunocompromised humans and mice [22-24].  4 
 5 
Memory Inflation: The CD8+ T cell response to CMV. 6 
CMV-specific CD4+ and CD8+ T cells are present in staggering numbers during 7 
the persistent infection in healthy people, comprising approximately 5% of all 8 
circulating T cells and 10% of all memory T cells in the average adult host [25]. 9 
Strikingly, the frequencies of virus-specific CD8+ T cells increase over the course 10 
of infection. This slow increase in the numbers or frequency of virus-specific 11 
CD8+ T cells has been referred to as “memory inflation” and occurs in both 12 
MCMV infected mice and HCMV infected people [26-33]. For the purposes of this 13 
review, “memory inflation” is used in its most basic sense: to describe the 14 
increasing numbers and frequency of CMV-specific CD8+ T cells over time. The 15 
general assumption has been that these “inflationary” CD8+ T cell populations 16 
are the direct result of ongoing viral activity. How these inflationary cells develop, 17 
how frequently they are stimulated and how they respond to each stimulation 18 
event remain open questions. 19 
 20 
Memory inflation of virus-specific CD8+ T cells is, in many ways, unique to CMV 21 
infection. It is generally agreed that the majority of inflationary CMV-specific T 22 
cells resemble extensively differentiated, but functional effector cells. This has 23 
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been investigated in both HCMV-infected people and MCMV-infected mice by 1 
many laboratories [26, 28, 30, 32-45] and an interesting picture has emerged. 2 
Most CMV-specific T cells express perforin and granzyme, they can kill antigen-3 
bearing target cells, and they can secrete IFN-γ and TNF-α, but only very little IL-4 
2. However, many of these cells bear phenotypic hallmarks of repeated antigen 5 
stimulation. For example, most CMV-specific T cells lack expression of the co-6 
stimulatory molecules CD27 and CD28, as well as L-selectin (CD62L) and the 7 
chemokine receptor CCR7 that allow for access to lymph nodes. Likewise, many 8 
CMV-specific effectors have reduced expression of the receptors for IL-7 and IL-9 
15, cytokines important for homeostatic maintenance of memory T cells. In 10 
humans, many of these T cells express the memory-marker CD45RO, but a 11 
subset, considered to be the most terminally differentiated, express CD45RA, a 12 
marker typically expressed by naïve T cells. CMV-specific CD8+ T cells with this 13 
phenotype have short telomeres, indicating an extensive proliferative history [46]. 14 
Importantly, the frequency of these cells directly correlates with the amount of 15 
virus at the peak of infection [37].  16 
 17 
In addition to the phenotype described above, CMV-specific inflationary T cells 18 
also upregulate a variety of NK-associated receptors including the activating 19 
receptor NKG2D and the inhibitory receptors NKG2A and KLRG-1 along with 20 
CD57 and CD85j in humans [31, 33, 47-50]. Expression of KLRG-1 in particular 21 
is associated with repeated antigen stimulation [51], although it is also 22 
upregulated by CD8 T cells during acute viral infections [52]. It is unclear how 23 
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CMV-specific T cells with this phenotype will be affected by this combination of 1 
reduced co-stimulatory molecule expression and increased inhibitory molecule 2 
expression. One possibility is that they have a restricted or decreased 3 
proliferative capacity after stimulation. Indeed, expression of the inhibitory 4 
molecules CD57 and KLRG-1, has been associated with reduced or absent 5 
proliferative potential (senescence) [47, 48, 53-56]. However, CMV-specific 6 
inflationary T cells do not appear to be senescent in healthy adult hosts. Although 7 
CMV-specific T cells undergo relatively little proliferation at steady state during 8 
chronic CMV infection [20, 28, 32, 38, 57, 58], T cells with the phenotype 9 
described can be induced to divide by the correct combination of stimuli. In 10 
particular, stimulating inflationary T cells through both the T cell receptor (TCR) 11 
and common γ–chain cytokine receptors results in cell division as does the 12 
simultaneous stimulation of both the TCR and 4-1BB (CD137, a member of the 13 
TNF-receptor family) [42, 43, 59]. Likewise, MCMV-specific inflationary cells 14 
divide after MCMV challenge in an adoptive transfer model [33]. It seems likely 15 
that additional co-stimulatory pathways will also push these inflationary T cells 16 
into cell cycle. Thus, CMV-specific inflationary T cells seem to be repeatedly 17 
stimulated, but functional effectors during chronic infection, at least in healthy 18 
adults, but require specific combinations of stimuli to enter cell cycle. For the 19 
remainder of this article, I will refer to CMV-specific inflationary cells with this 20 
phenotype as effector T cells (TEFF) to distinguish them from small populations 21 
that retain a more memory-like phenotype (described below). 22 
 23 
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CMV-specific “memory-like” T cells 1 
The accumulation of the CMV-specific T cells with the phenotype described 2 
above is contrasted by a persistence of other T cells with a more memory-like 3 
phenotype. Many of these memory-phenotype cells do not recognize the same 4 
antigens as the TEFF cells that undergo memory inflation. CMV infection in both 5 
mice and humans elicits T cells specific for a broad array of antigens [25, 60] and 6 
many of these T cells contract after acute infection and persist at low levels 7 
thereafter [30, 32, 33]. These “non-inflationary” T cells tend to develop a more 8 
classical memory phenotype (i.e. retention of co-stimulatory molecules and 9 
cytokine receptors and an absence of inhibitory receptors), suggesting that they 10 
may not be repeatedly stimulated despite the persistent infection. Recent data 11 
have suggested that these non-inflationary T cells may recognize peptides that 12 
depend on the immunoproteasome for production [61]. Since non-professional 13 
antigen presenting cells do not constitutively express the immunoproteasome, 14 
these peptides may be rarely produced during chronic infection. However, there 15 
are also small subsets of cells that retain a memory-like phenotype despite 16 
sharing peptide specificity with large numbers of TEFF cells, which can not be 17 
explained by limited peptide presentation. 18 
 19 
Using the mouse model of MCMV infection in C57BL/6 mice, we and others have 20 
begun dissecting the array of CD8+ T cell responses elicited by MCMV over time. 21 
We typically analyze T cells specific for 5 different viral antigens: M45, M57, 22 
m139, M38 and IE3. Schematics of the kinetics of these T cell responses are 23 
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illustrated in Figure 1a. T cells specific for M45 and M57 contract after acute 1 
infection and develop a memory-like phenotype at late times post infection, 2 
illustrated here by high levels of CD127 (IL-7Rα) expression and little KLRG-1 3 
expression (Figure 1b and [30, 33]). These are prototypical examples of non-4 
inflationary T cells. In contrast, inflationary T cells specific for the viral antigens 5 
m139, M38 and IE3 accumulate after MCMV infection, each with distinct kinetics 6 
(Figure 1a). These cells mostly develop a TEFF phenotype, illustrated here by a 7 
downregulation of CD127 and expression of KLRG-1 (Figure 1b). However, there 8 
is always a small subset of inflationary T cells (m139-, M38- or IE3-specific) that 9 
retain CD127 expression and do not upregulate KLRG-1 (upper left quadrants in 10 
Figure 1b). These  memory-phenotype inflationary cells generally comprise less 11 
than 10-15% of the total antigen-specific pool (Figure 1c) and there is only a little 12 
data hinting at their functional capacity: HCMV-specific T cells that are memory-13 
phenotype tended to expand better than TEFF HCMV-specific T cells after 14 
allogeneic stem cell transplantation [62] and our data [33] implied that MCMV-15 
specific CD8+ T cells with a memory-phenotype expanded more robustly than 16 
TEFF cells with the same specificities after viral challenge. If memory is defined by 17 
the speed and magnitude of recall responses, these data suggest that the 18 
memory-phenotype cells are more “memory-like” than their TEFF counterparts, 19 
although more work is needed to define these differences. 20 
 21 
The mechanisms dictating whether individual T cells with a given specificity will 22 
remain memory-like or differentiate into effectors during chronic infection are 23 
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currently unclear. Analyses of HCMV-specific CD8+ T cells indicate that 1 
individual T cell clones can be found within both TEFF and memory-like 2 
populations [63], indicating that segregation or selection into either subset is not 3 
dependent on a particular T cell receptor. Are TEFF cells, as their phenotype may 4 
suggest, the only cells that respond to viral antigens during chronic infection? If 5 
memory-like cells are stimulated, what is their fate? Likewise, what is the fate of 6 
TEFF cells stimulated during chronic infection? More precise measurements of the 7 
development, maintenance, behavior and functional potential of these two 8 
inflationary T cell subpopulations are needed to begin addressing these 9 
questions. However, for the remainder of this article, I would like to consider the 10 
idea that both of these populations work in tandem to enable the maintenance of 11 
life-long, functional CMV-specific immunity. 12 
 13 
Short or long-lived CMV-specific CD8+ T cells. 14 
Given the absence of substantial proliferation within CMV-specific inflationary 15 
populations [20, 28, 32, 38, 57, 58], there are two basic hypotheses describing 16 
the homeostasis and persistence of inflationary TEFF cells. The first suggests that 17 
CMV-specific T cells are long-lived, resting effectors (discussed in [64]). This 18 
model states that CMV-specific T cells are functional effectors that will circulate 19 
for long periods of time and suppress reactivating or replicating virus when it is 20 
encountered. These TEFF cells may not undergo much or any cell division after 21 
each stimulation event unless the conditions are ideal (e.g. appropriate co-22 
stimulation and/or cytokine signals). Supporting this model is the evidence that 23 
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individual CMV-specific clones of cells can persist for several years [63, 65]. In 1 
addition, in humans, CD45RA+ CMV-specific T cells only emerge after acute 2 
infection has been resolved [45]. As restimulation of these cells in vitro promotes 3 
re-expression of CD45RO [44], these data may imply that the CD45RA+ subset 4 
of CMV-specific T cells are resting and have not been recently stimulated. Thus, 5 
in this model, a long half-life and only occasional cell division, driven by a specific 6 
combination of stimuli, maintain the population. 7 
 8 
The alternate hypothesis states that CMV-specific T cell populations are 9 
extremely dynamic, comprising mostly short-lived effector cells that are 10 
continually replaced as they die, thus maintaining the population as a whole 11 
(Figure 2). We proposed this model because inflationary MCMV-specific T cells 12 
from the spleens of chronically infected mice failed to sustain themselves after 13 
adoptive transfer into either naïve or chronically infected animals [33]. In the 14 
presence of virus, CMV-specific T cells underwent some cell division, but not 15 
enough to maintain their numbers, and the transferred populations slowly 16 
decayed with a half-life of approximately 1 to 2 months. Thus, we proposed that 17 
the majority of inflationary T cells were actually short-lived effectors, similar in 18 
phenotype (CD127low, KLRG-1pos, Figure 1b) and function to short-lived effector 19 
cells elicited by acutely cleared infections [66]. Consistent with this model, it was 20 
shown that CD127low (TEFF) inflationary T cells express less of the anti-apoptotic 21 
molecule Bcl-2 than cells with the same specificity that retained CD127 22 
expression (memory-like cells) [32]. This could imply that TEFF inflationary cells 23 
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are more prone to apoptosis than memory-like inflationary T cells. Moreover, 1 
recent evidence has shown that HCMV elicited CD45RA+, CD4+ T cells (the 2 
most differentiated) are susceptible to apoptosis after antigen-stimulation in vitro 3 
[67]. Although still unclear, it is interesting to speculate that both CD4+ and CD8+ 4 
CMV-specific T cell populations may be dominated by short-lived populations. 5 
 6 
Short-lived TEFF cells might be repeatedly produced by more memory-like T 7 
cells. 8 
In our model, there must be a continuous source of new short-lived effector cells 9 
to replace those that die in order for the inflationary populations to be maintained 10 
(Figure 2). Our data showed that naïve T cells can be recruited during chronic 11 
infection to provide some new effector cells [33] and a similar model was 12 
proposed to account for maintenance of murine polyomavirus-specific T cells [68, 13 
69]. However, we further showed that insufficient numbers of T cells were 14 
recruited from the naïve pool to account for maintenance of the MCMV-specific 15 
inflationary populations [33]. Instead our data suggested that a population of T 16 
cells produced early in the infection could maintain the inflationary T cell pool. 17 
Thus, T cells transferred only 7 days after infection into infection matched 18 
recipients could provide long-term maintenance of the donor populations. We 19 
interpreted these data to suggest that some sort of memory or memory-like 20 
population was generated during primary infection and then repeatedly 21 
stimulated to produce new short-lived TEFF cells via clonal expansion (Figure 2). 22 
As long as the production rate of new TEFF cells exceeded their rate of loss, the 23 
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result would be memory inflation. Once the production rate of TEFF cells equaled 1 
the rate of loss, the population would persist at an elevated, but stable level. 2 
 3 
Since clones of memory-like cells would be responsible for repeatedly producing 4 
TEFF cells, this model is consistent with the fact that individual HCMV-specific 5 
CD8+ T cell clones are found in both TEFF and memory-like subsets [63]. In 6 
addition, this model could explain the maintenance of certain T cell clones over 7 
many years: a small pool of memory-like cells would produce TEFF cells with a 8 
limited clonal composition and individual clones would develop into effectors 9 
repeatedly over time. If some clones were present at higher frequencies in the 10 
memory-like pool, or possessed T cell receptors within an ideal avidity range, 11 
these would undoubtedly be selected into the TEFF pool more frequently. Thus, 12 
competition between the memory clones could explain the selection of some but 13 
not all clones over time. Interestingly, a study by Day et. al. [65] showed that 14 
within a few weeks of primary HCMV infection, a relatively small number of T cell 15 
clones were selected into the CD8+ T cell population specific for a given peptide 16 
and that the relative frequency of individual clones fluctuated with time. Although 17 
fluctuations in clonal frequency from time point to time point might represent 18 
more or less comprehensive blood sampling, such fluctuations would also be 19 
predicted by a model in which different clonal expansions contribute to the 20 
maintenance of the whole population.  21 
 22 
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If memory-like T cells are responsible for clonal expansions that support a 1 
circulating TEFF pool, where might such memory clones reside? In our 2 
experiments [33], CMV-specific populations from the spleen were unable to 3 
sustain themselves. Thus, any memory population in the spleen was either 4 
incapable of supporting memory inflation after adoptive transfer, or was 5 
transferred in insufficient numbers to support the donor antigen-specific pool. 6 
Alternative locations such as the bone marrow or lymph nodes may harbor 7 
increased numbers of the relevant cell population. Interestingly, while the 8 
frequency of memory-phenotype inflationary cells was greater in the spleen and 9 
bone marrow relative to the blood, there was little or no difference between the 10 
bone marrow and the spleen (Figure 1b and c). It remains formally possible that 11 
bone marrow resident memory cells are functionally distinct from spleen resident 12 
cells however, requiring further experiments to test the functional properties of 13 
these subsets. 14 
 15 
It must be noted however, that because we used adoptive transfer experiments 16 
to test the persistence of MCMV-specific T cells, there is an alternative 17 
explanation for our results: CMV-specific T cells (either TEFF cells, memory-like 18 
cells or both) may require a specific niche in which to survive. Thus, when we 19 
transferred MCMV-specific T cells into chronically infected mice, the niches in the 20 
host may have been filled with the host’s own MCMV-specific T cells, thereby 21 
excluding the donor cells. It is possible that this niche is not filled early 22 
(explaining our ability to transfer self-sustaining populations at day 7 post 23 
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infection) but could fill over time with memory inflation. Studies specifically 1 
designed to investigate the survival and engraftment of transfused MCMV-2 
specific T cells are required. 3 
 4 
CMV-specific T cells for adoptive therapy: 5 
The difference between these two models (short- vs. long-lived inflationary T 6 
cells) may have a significant impact on the development of adoptive 7 
immunotherapy for immune compromised patients. There are no therapies for 8 
boosting CMV-specific T cell responses in immune compromised patients. 9 
Therefore, several groups have been working to develop methods for the 10 
isolation and passive transfusion of CMV-specific T cells from healthy donors into 11 
immune compromised recipients at risk for CMV disease (recently reviewed in 12 
[70]). Typically, CMV-specific T cells have been isolated based on their ability to 13 
secrete IFN-γ after antigen-stimulation although in some cases, T cell clones or 14 
directly sorted, tetramer-binding T cells have been used. These procedures have 15 
yielded some promising results, but are still experimental and costly and 16 
questions still remain about how to ensure persistence of effective donor T cells 17 
after transfusion. Indeed, transfused T cells can only provide protection for as 18 
long as they survive. If the majority of isolated T cells are short-lived and 19 
continuously replaced, the challenge may be to transfer a self-sustaining 20 
population that can control CMV over long periods of time. Interestingly, the 21 
Riddell group, pioneers of this therapeutic approach to mitigate CMV infection 22 
[19, 24], have shown using a non-human primate model of CMV infection, that T 23 
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cell clones derived from “central memory” (CD28+, CD95+) but not more 1 
differentiated “effector memory” (CD28-, CD95+) subsets persist after adoptive 2 
immunotherapy [71]. These data support the idea that CMV-specific TEFF cells 3 
may be less effective than more memory-like populations over long periods of 4 
time. If we can develop an understanding of precisely how CMV-specific 5 
populations are generated and sustained, it may become possible to transfuse 6 
more protective or longer lasting CMV-specific populations or even to promote 7 
these cells directly in immune compromised patients. 8 
 9 
T cell exhaustion: A paradigm for several chronic infections. 10 
Aside from the homeostasis of CMV-specific TEFF and memory-like T cells, their 11 
maintenance of effector function is also remarkable. The development of 12 
dysfunctional CD8+ T cells, generally called T cell “exhaustion”, occurs during 13 
several other chronic infections including Hepatitis C, Hepatitis B, HIV, and in the 14 
mouse models of chronic lymphocytic choriomeningitis virus (LCMV) infection 15 
(recently reviewed in [72]). Exhaustion during these infections is typically 16 
characterized by a progressive loss in the ability of CD8+ T cells to produce 17 
cytokines (first IL-2, then TNF-α and eventually IFN-γ), as well as to survive, 18 
proliferate and kill targets. However, there is little evidence of such exhaustion 19 
occurring during CMV infection except in immune compromised patients with 20 
high titers of replicating CMV [73, 74]. Indeed, exhaustion appears to be a 21 
defined molecular program induced in T cells by some chronic infections [75] and 22 
gene expression profiles of HCMV-specific T cells do not conform to this 23 
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molecular signature [38]. Notably, during chronic CMV infection in healthy 1 
humans and mice, CMV-specific T cells do not upregulate PD-1 [20, 38], one 2 
inhibitory molecule that is strongly associated with antigen-driven T cell 3 
exhaustion. Indeed, even in the absence of CD4+ T cell help, an environment 4 
that accelerates and exacerbates CD8+ T cell exhaustion after chronic LCMV 5 
infection [76, 77], only relatively mild CD8+ T cell dysfunction develops after 6 
MCMV infection, despite the additional fact that MCMV is never fully controlled in 7 
the absence of CD4+ T cells [20, 21]. 8 
 9 
One explanation for the lack of exhaustion during CMV infection is that CMV is a 10 
“smoldering” infection [72, 76], with ongoing viral replication never reaching 11 
levels that can drive T cell dysfunction in healthy hosts. In line with this, T cell 12 
exhaustion in mice infected with LCMV-clone 13, a virus that replicates to high 13 
titers, is associated with continuous antigen-driven T cell proliferation [78] while 14 
CMV-specific T cells undergo relatively little proliferation during chronic infection 15 
in both humans and mice [20, 28, 32, 38, 57, 58]. As mentioned above, this is not 16 
because CMV-specific T cells are unable to proliferate. The correct combination 17 
of stimuli will drive even TEFF phenotype cells into cell cycle [42, 43, 59]. Thus, 18 
either CMV-specific T cells rarely encounter antigen, or they are frequently 19 
stimulated by antigen, but rarely driven into cell cycle. Perhaps the expression of 20 
inhibitory molecules by TEFF cells and their dependence on cytokines and/or 21 
certain co-stimulatory signals limits cell division and thus, exhaustion. This may 22 
be especially true since many TEFF cells can be found within non-lymphoid 23 
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organs [26, 28, 32], where they may be exposed to much of the antigen 1 
produced by reactivating virus [5, 79], but not the cytokines or co-stimulatory 2 
molecules necessary for cell division [42, 43, 59]. Consistent with this idea, 3 
continuous MCMV replication in CD4+ T cell deficient mice was necessary to 4 
support the size of inflationary CD8+ T cell populations [21], but did not result in 5 
markedly increased proliferation by inflationary CD8+ T cells [20]. Thus, even in 6 
this scenario, where it was clear that MCMV-specific CD8+ T cells responded to 7 
antigen from a continuously replicating virus, they still underwent relatively limited 8 
cell division. Therefore, proliferation may be a poor indicator of how frequently 9 
MCMV-specific T cells encounter antigen and it is possible that the TEFF state, 10 
with its specific requirements for entering the cell cycle, may itself prevent the 11 
development of exhaustion, regardless of how frequently these cells are 12 
stimulated.  13 
 14 
Buffered Memory: A hypothesis to explain the preservation of functional 15 
memory CD8+ T cells during persistent CMV infection 16 
Regardless of how the CMV-specific TEFF cells remain functional, an additional 17 
mystery is the preservation of functional memory-like cells during chronic MCMV 18 
infection. Perhaps the TEFF cells, by recognizing the majority of viral antigen and 19 
controlling the majority of viral gene expression, simply prevent the memory-like 20 
T cells from being overstimulated during persistent CMV infection. If TEFF cells 21 
suppress viral reactivation in the tissue effectively, their presence should limit the 22 
antigen burden placed on the more memory-like cells, thus preventing memory-23 
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like cells from responding to all but a fraction of viral antigen (Figure 3). In this 1 
way, perhaps the TEFF cells act as a buffer for the memory-like cells and only 2 
occasional “leaks” of viral antigen or perhaps antigen expression in a particular 3 
environment (e.g. a specific cell type or organ) stimulate the memory-like T cells. 4 
Perhaps, without TEFF cells CMV-specific memory cells might otherwise be driven 5 
to undergo terminal differentiation or become exhausted while occasional 6 
stimulation might act more like a vaccine boost, inducing the memory-like cells to 7 
undergo clonal expansion and produce more TEFF cells, thereby adding to and 8 
supporting the whole CMV-specific inflationary population. Thus, the immune 9 
system may not be capable of accumulating or sustaining TEFF cells without a 10 
memory population to produce more TEFF cells as needed (especially if TEFF cells 11 
are short-lived), while the memory population might not persist in a functional 12 
state without being shielded from the majority of antigen. 13 
 14 
Concluding Remarks: 15 
The model presented here is obviously only relevant if the CMV-specific memory-16 
like cells play some role in the development or maintenance of memory inflation. 17 
To investigate the models proposed here, it will be important to determine the 18 
effect of stimulating both TEFF and memory-like CMV-specific T cells during 19 
chronic infection. Are the memory-like cells depleted over time or can they 20 
sustain themselves through repeated rounds of stimulation? Are memory-like 21 
cells stimulated at a different rate than TEFF cells? Are TEFF cells short- or long-22 
lived and can they persist in a functional state in the absence of memory-like 23 
  22
cells with the same specificity (e.g. when transferred into immune compromised 1 
hosts infected with MCMV)? The answers to these questions will hinge on how 2 
much antigen stimulation occurs during chronic infection, how it impacts the 3 
virus-specific T cells and where that stimulation takes place for both TEFF and 4 
memory-like cells. Recent experiments have begun to shed light on some of the 5 
details, suggesting that memory inflation depends on antigen-presentation by 6 
non-hematopoietic cells [80] and that direct presentation of antigen by infected 7 
cells is sufficient for memory-inflation [81]. Together, these observations fit nicely 8 
with the evidence that inflationary T cells recognize peptides that can be 9 
produced by non-professional antigen presenting cells lacking 10 
immunoproteasomes [61]. In addition, our recent data showed that a limited 11 
subset of cells infected by MCMV in the first round of infection were sufficient to 12 
stimulate memory inflation (Snyder et. al, PLoS Pathogens, in press). It will be 13 
interesting to determine which cells are responsible for presenting viral antigens 14 
and whether they stimulate T cell division, recruitment or differentiation, or rather 15 
prolong the survival of TEFF cells so that the rate of TEFF cell production exceeds 16 
the rate of loss, resulting in accumulation. 17 
 18 
Aside from the basic goals of understanding the complex relationship between 19 
CMV and its host, the answers to the questions outlined in this review may be 20 
relevant for promoting sustainable CMV-specific immunity in patients at risk for 21 
CMV disease. Whether or not the models described here are ultimately 22 
supported by the data, it will be important to determine how the homeostasis of 23 
  23
CMV-specific T cells is influenced by factors such as pro- and anti-inflammatory 1 
cytokines, co-stimulatory and inhibitory receptors, and different types of antigen-2 
presenting cells. Finally, it will be interesting, as we learn more, to determine 3 
whether the mechanisms that support life-long immunity to CMV are broadly 4 
applicable to other chronic infections within the herpesvirus family or by unrelated 5 
pathogens. 6 
 7 
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Figure Legends: 1 
 2 
Fig. 1 Antigen-specific T cells with an effector- or memory-phenotype develop 3 
during MCMV infection in C57BL/6 mice.  a) Schematic of the kinetics of CD8+ T 4 
cells specific for 5 different MCMV antigens. b) Representative FACS plots of 5 
inflationary and non-inflationary T cells in the blood, spleen and bone marrow of 6 
mice infected for 19 weeks with MCMV. The data show the expression of CD127 7 
(IL-7Rα) and KLRG-1 for all CD8+ T cells (left most panels) or CD8+ T cells that 8 
also bound to MHC-tetramers loaded with the indicated peptides. All FACS plots 9 
were taken from a single animal for comparison. c) Average (n = 5 mice) 10 
frequency of CD127hi, KLRG-1neg, memory-phenotype T cells specific for each of 11 
the indicated antigens. Data were derived from the upper left quadrants of the 12 
FACS plots gated as shown in b. p-values were derived from a student’s t-test for 13 
paired data. 14 
 15 
Fig. 2  Two proposed models to explain the persistence of MCMV-specific CD8+ 16 
T cells during memory inflation. The schematic on the left describes cells that are 17 
long-lived or self-sustaining. The schematic on the right describes a situation in 18 
which inflationary T cells are repeatedly replenished by clonal expansions, 19 
perhaps from a small memory-like pool of cells specific for the same peptides. In 20 
this model, a dominant T cell clone (represented by the light colored expansions) 21 
is selected to undergo clonal expansion more frequently. Such clonal dominance 22 
could be explained by an increased number of cells within this clone, or perhaps 23 
a “better fit” T cell receptor. When sub-dominant clones are stimulated, the 24 
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composition of the inflationary pool is predicted to change (indicated by the 1 
dotted lines). 2 
 3 
Fig. 3  Buffered memory: A model to explain the persistence of functional 4 
memory during chronic CMV infection. In this model, a large number of effector-5 
phenotype T cells traffic to and accumulate in non-lymphoid organs, where the 6 
majority of latent virus resides. These cells control most viral reactivation, 7 
typically prior to virion production, and prevent memory-like T cells from 8 
experiencing antigen stimulation. Occasional antigen “leaks” or expression of 9 
viral antigens in a specific cell type or organ, might lead to stimulation of 10 
memory-like cells (indicated by the down-facing arrow) and new clonal 11 
expansions (upward, curved arrow) that produce large numbers of effector-12 
phenotype T cells to join the pool of effector cells in the periphery. 13 
 14 
